Abstract
Cardiovascular and cerebrovascular diseases (CCVD) are a major and increasing health burden worldwide. Although treatments have been made a certain progress, the development of novel therapies for patients remains a major research object. There are a lot of drugs against CCVD, but most of them lack tissue specificity with a short half-life, which seriously limits their extensive clinical application. Utilization of some pathophysiological changes caused by CCVD, targeted drug distribution in CCVD patients could be achieved. The current review aims to capture various drug delivery systems transporting drug specifically to vascular disease, including passive, active and physicochemical targeted delivery carriers. Their design strategies and mechanisms are described in detail. The present limitations and future perspective are also discussed.
Keywords: Cardiovascular and cerebrovascular diseases, pathophysiological changes, passive, active, physicochemical, targeting, drug delivery, carriers.
Current Drug Targets
Title:Targeted Drug Delivery for Cardiovascular and Cerebrovascular Diseases
Volume: 17 Issue: 4
Author(s): Jingjing Luan and Guangxi Zhai
Affiliation:
Keywords: Cardiovascular and cerebrovascular diseases, pathophysiological changes, passive, active, physicochemical, targeting, drug delivery, carriers.
Abstract: Cardiovascular and cerebrovascular diseases (CCVD) are a major and increasing health burden worldwide. Although treatments have been made a certain progress, the development of novel therapies for patients remains a major research object. There are a lot of drugs against CCVD, but most of them lack tissue specificity with a short half-life, which seriously limits their extensive clinical application. Utilization of some pathophysiological changes caused by CCVD, targeted drug distribution in CCVD patients could be achieved. The current review aims to capture various drug delivery systems transporting drug specifically to vascular disease, including passive, active and physicochemical targeted delivery carriers. Their design strategies and mechanisms are described in detail. The present limitations and future perspective are also discussed.
Export Options
About this article
Cite this article as:
Luan Jingjing and Zhai Guangxi, Targeted Drug Delivery for Cardiovascular and Cerebrovascular Diseases, Current Drug Targets 2016; 17 (4) . https://dx.doi.org/10.2174/1389450116666150416120224
DOI https://dx.doi.org/10.2174/1389450116666150416120224 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Anti-Oxidative Polyphenolic Compounds of Cocoa
Current Pharmaceutical Biotechnology Insulin and the Brain
Current Diabetes Reviews Diabetes and Antioxidants: Myth or Reality?
Current Vascular Pharmacology Potential Role of Calcium/Calmodulin-dependent Protein Kinase II to Angiogenesis Mediated Pathological Changes Seen in Osteoarthritis
Current Angiogenesis (Discontinued) Interactions of Ginkgolides A and B with a Recombinant Human Prion Protein
Protein & Peptide Letters Differential Impacts of Antihypertensive Drugs on Central Blood Pressure and Their Clinical Significance
Current Hypertension Reviews Genomics, Proteomics and Metabolomics Approaches for Predicting Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients
Current Diabetes Reviews The Ultrasonographic Diagnosis of Polycystic Ovary Syndrome
Current Medical Imaging Omega-3 and Renal Function in Older Adults
Current Pharmaceutical Design Benefits of L-Arginine on Cardiovascular System
Mini-Reviews in Medicinal Chemistry Epidemiology of Major Congenital Malformations with Specific Focus on Teratogens
Current Drug Safety Cutting through the Complexities of mTOR for the Treatment of Stroke
Current Neurovascular Research Leptin and the Ob-Receptor as Anti-Obesity Target: Recent In Silico Advances in the Comprehension of the Protein-Protein Interaction and Rational Drug Design of Anti- Obesity Lead Compounds
Current Pharmaceutical Design Post-Translational Protein Modifications of Rare and Unconventional Types: Implications in Functions and Diseases
Current Medicinal Chemistry The Pathophysiology of CTGs and Types of Intrapartum Hypoxia
Current Women`s Health Reviews Highest Mortality During the Last Year Before and the First Year After Start of Dialysis Treatment in Type 2 Diabetic Patients with Nephropathy
Current Diabetes Reviews Chemokines and Atherosclerotic Plaque Progression: Towards Therapeutic Targeting?
Current Pharmaceutical Design The Potential of Microalgae for the Production of Bioactive Molecules of Pharmaceutical Interest
Current Pharmaceutical Biotechnology Patent Selections
Recent Patents on Drug Delivery & Formulation Pleural Involvement in Systemic Disorders
Current Drug Targets - Inflammation & Allergy